PRINCETON, N.J., Feb. 12, 2014 (GLOBE NEWSWIRE) -- Advaxis, Inc. (Nasdaq:ADXS), a biotechnology company developing the next generation of cancer immunotherapies, announced that Robert G. Petit, Ph.D., Chief Scientific Officer of Advaxis, will be presenting on an expert panel titled “The Future of Cancer Immunotherapy” during the Bloomberg 2014 State of Healthcare Summit on Friday, February 14, 2014 at 11:15 a.m. ET. The conference will be held at Bloomberg’s offices at 731 Lexington Avenue, New York, NY 10022.
Help employers find you! Check out all the jobs and post your resume.
